The formal reports of the work conducted by the MicroArray Quality Control (MAQC) consortium lay the groundwork for microarrays to gain acceptance as a clinical diagnostic and drug development tool.

The potential medical applications of microarrays have generated much excitement, and some skepticism, within the biomedical community. Some researchers have suggested that within the decade ...

The main conclusion: consistency across sites and between platforms is generally high. For instance, "all one-color microarray platforms had a median CV [coefficient of variance] of 5-15% for the ...

There's no denying the popularity of DNA microarrays: 1.8 billion data points in the Stanford Microarray Database don't lie. But a lack of standards and quality control metrics for everything from RNA ...

The FDA's Microarray Quality Control project has delivered a badly needed endorsement of the microarray technologies out on the market. Spurred by studies that suggested varying results among the ...

Microarray technology has come of age as a powerful approach to revealing the genome and its dynamic expression through the application of gene-hybridization or gene-expression microarrays. While the ...

The Microarray Core Facility is a component of the UAlbany Center for Functional Genomics and was established to provide the infrastructure to enable the development of major projects that utilize DNA ...